Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-08
1998-07-14
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549354, A61K 31335
Patent
active
057805016
ABSTRACT:
##STR1## wherein alk is a divalent aliphatic radical, R is an amino group that is unsubstituted or mono- or di-substituted by monovalent aliphatic and/or araliphatic radicals or disubstituted by divalent aliphatic radicals, and R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are each, independently of the others, hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl, and pharmaceutically acceptable salts thereof, may be used as anti-neurodegenerative active ingredients of medicaments. The invention relates also to novel compounds of formula I.
REFERENCES:
patent: 3100207 (1963-08-01), Zirkle et al.
patent: 3641056 (1972-02-01), Schindler et al.
patent: 3928383 (1975-12-01), Kaplan et al.
Chemical Abstract, vol. 85, No. 11, Sep. 13, 1976, No. 77999v.
Chemical Abstract, vol. 81, No. 19, Nov. 11, 1974, No. 120510k.
Chemical Abstract, 85:78000z, (1976).
Betschart Claudia
Zimmermann Kaspar
Ferraro Gregory
Mathias Marla J.
Novartis Corporation
Ramsuer Robert W.
LandOfFree
Treatment method using anti-neurodegeneratively active does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment method using anti-neurodegeneratively active, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment method using anti-neurodegeneratively active will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1882195